A Prospective Trial of the Microneedle Fractional Radiofrequency System Application in the Treatment of Infraorbital Dark Circles
Xianglei Wu,Ying Liu,Jiafang Zhu,Wenxin Yu,Xiaoxi Lin
DOI: https://doi.org/10.2147/CCID.S372409
2022-07-08
Abstract:Xianglei Wu, 1, &ast Ying Liu, 1, &ast Jiafang Zhu, 1, &ast Wenxin Yu, 1 Xiaoxi Lin 1, 2 1 Department of Laser and Aesthetic Medicine, Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, People's Republic of China; 2 Department of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China &astThese authors contributed equally to this work Correspondence: Wenxin Yu; Xiaoxi Lin, Department of Laser and Aesthetic Medicine, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China, Email ; Background: Infraorbital dark circles (IDC) are commonly consulted in aesthetic practice. There is not yet a multifactorial approach to facilitating their treatment. Objective: To investigate the safety and efficacy of the microneedle fractional radiofrequency (MRF) system for the treatment of IDC. Methods: A prospective, split-face, evaluator-blind clinical trial was conducted to study the change in the overall appearance, color, and wrinkles in 21 female patients with mixed type IDC before and after MFR treatment. Results: Both patients and independent evaluators found significant improvement on the global aesthetic scales after the MFR treatment, especially on periorbital wrinkles (p=0.031). Trends in decreased melanin density in the IDC area were found, but no statistical differences were established. No side effects were observed. Conclusion: MFR is a safe and effective modality for improving mixed type IDC by correcting the structural factors. Keywords: infraorbital dark circles, microneedle fractional radiofrequency, radiofrequency, periorbital hyperpigmentation Infraorbital dark circles (IDC) are generally defined as bilateral semicircular hyperpigmentation in the infraorbital region. 1 As a common presentation of periorbital melanosis, this entity is frequently consulted in dermatology practice not only due to aesthetic blemish but also to a negative impact on the quality of life. 2 To date, there is little evidence reported on its global prevalence. We have identified limited data on some reported cases, mostly researching literature. In the Indian population, for example, IDC are reported most commonly in females (81%) and are predominant in younger people (16–25 years old, 47.5%). 3 Still, we have a poor understanding of the IDC etiology. Studies report that exogenous (atopic dermatitis, ultraviolet, trauma, etc.) and endogenous (genetics, superficial location of the vasculature, tear trough, the extension of pigmentary demarcation lines of the face) factors independently or collaboratively cause IDC. 4 IDC is classified into a pigmented, vascular, structural, and mixed type according to the primary cause of pathogenesis. 5 The treatment strategy is commonly determined based on the IDC clinical type. For instance, therapeutic options for pigmented IDC include topical depigmenting agents, chemical peels, surgical corrections, and laser therapy, focused on treating hyperpigmentation. However, as the mixed type represents the significant majority of IDC; 5 therefore, multiple therapeutic modalities are usually needed. While such a strategy is time- and cost-consuming, it also presents potential risks. The therapeutic effect of monopolar radiofrequency is reported to improve periorbital skin laxity and wrinkles, 6 which are common contributing factors of the structural IDC. An MFR system, which delivers radiofrequency energy through a fractional microneedle electrode assembly with adjustable length, has been used in treating photoaging, acne vulgaris, and scarring. 7 Recent studies reported its application in hyperpigmentation, erythema, vascular malformation, and lipolysis. 8–12 Given the previously mentioned pathogenesis of IDC, MFR could theoretically target most of the primary causes using a single device. Our study aimed to investigate the potential utility and safety of MFR in Chinese patients as a novel therapeutic modality of IDC. This study was conducted in the Department of Laser and Aesthetic Medicine of the Shanghai Ninth People's Hospital. As a prospective split-face study, all participants left side of the face was treated with IDC, and their right sides were considered the control side. This study was approved by the Ethical Committee of Shanghai Ninth People's Hospital (SH9H-2019-T127-2) and was performed according to the principles of the Declaration of Helsinki. The patients -Abstract Truncated-